VERA FY 2022 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$846,000

Operating Income

-$91M

Net Income

-$89M

EPS (Diluted)

$-3.35

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$68M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$131M

Total Liabilities

$55M

Stockholders' Equity

$77M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$846,000	$0	—
Operating Income	-$91M	-$34M	-164.2%
Net Income	-$89M	-$33M	-173.1%